Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.26% | 203.42 | 1.3% | $752.26m | |
| GILD | Gilead Sciences, Inc. | 0.14% | 64.22 | 0.9% | $374.75m | |
| CELG | Celgene Corporation | 0.03% | 95.71 | 1.3% | $325.97m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 7.53% | 123.49 | 2.0% | $306.94m | |
| ILMN | Illumina, Inc. | -0.66% | 288.58 | 3.5% | $277.12m | |
| BIIB | Biogen Inc. | -0.48% | 232.06 | 1.3% | $268.05m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.16% | 184.24 | 1.9% | $256.63m | |
| EXAS | Exact Sciences Corporation | -1.14% | 117.87 | 24.1% | $239.89m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.93% | 295.02 | 2.6% | $203.40m | |
| A | Agilent Technologies, Inc. | -0.69% | 71.70 | 1.6% | $193.78m | |
| SRPT | Sarepta Therapeutics, Inc. | -6.34% | 95.07 | 14.7% | $184.59m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.05% | 77.40 | 4.3% | $97.47m | |
| INCY | Incyte Corporation | -0.59% | 85.56 | 2.5% | $96.06m | |
| GHDX | Genomic Health, Inc. | -1.12% | 73.52 | 1.8% | $85.99m | |
| SGEN | Seattle Genetics, Inc. | -2.01% | 78.36 | 6.5% | $79.57m |
Company Profile
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.